do semaglutides cause muscle loss GLP-1 drugs such as semaglutide and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant loss. A new India-specific consensus highlights How to Maintain Muscle Mass

Consistent with the idea that the AngII stimulated I sc increase might reflect a response to ATP, basolateral application of exogenous ATP (50 M) to mucosal preparations itself induced a transient increase in I sc (Fig

Microbiota Transplantation Microbiota transplants from mouse models (105) and humans (45, 106) into GF mice have successfully demonstrated the transmissibility of donors phenotypes

By focusing on lifestyle fit, expectations, and individual barriers, diabetes care and education specialists can help patients choose the option that aligns with their goals and supports long-term success

They are NAD+-dependent, meaning they require NAD+ to function

GLP-1 receptor agonists have now received FDA approvals for cardiovascular risk reduction, obstructive sleep apnea, and chronic kidney disease, in addition to their original diabetes and obesity indications

(If you can pronounce that, you win a prize.) The anonymous man applied for retatrutide in April through the FDAs compassionate use program, which lets seriously ill patients access treatments that are still in development